Since October 2019, +RNAinsight has revolutionized germline genetic testing for hereditary cancer and has provided clinically actionable results to many patients and families who may have otherwise received a negative or inconclusive result from DNA-only testing. Here are some highlights from the first year.
- +RNAinsight: A Year in Review | Ambry Genetics ( Download)
- Gene Specific Cancer Associations and Sensitivity of Genetic Testing Criteria | Ambry Genetics ( Download)
- See the Difference with Ambry’s Variant Assessment Team | Ambry Genetics ( Download)
- Will RNA testing be the next Del/Dup for Clinical Genetics | Webinar | Ambry Genetics ( Download)
- Improvements in Clinical Interpretation of Copy Number Variants CNVs | Webinar | Ambry Genetics ( Download)
- Genetic Testing with Ambry Genetics ( Download)
- Genetic Screening for Everyone or Just a Selected Few - ACOG 2018 ( Download)
- Leveraging Innovation to Improve the Identification of Patients with Hereditary Cancer ( Download)
- Aliso Viejo - Ambry Genetics - Business of the Month March 2021 ( Download)
- RNA Insight Pt 1 ( Download)
- Navigating NOW Virtual Roundtable EP025: Tom Schoenherr - CCO, Ambry Genetics ( Download)
- Hereditary Cancer Conference: Keynote - The Past, Present, and Future of Lynch Syndrome ( Download)
- Section 5 - The Science and Art of Clinical Genetic Variant Classification ( Download)
- Full Recording of the October 2023 ICARE Genetics Case Conference ( Download)
- One Size Does Not Fit All: Precision Medicine Virtual Panel ( Download)
